1. RNA sequencing uncovers the key long non‑coding RNAs and potential molecular mechanism contributing to XAV939‑mediated inhibition of non‑small cell lung cancer
   Haixiang Yu et al, 2019, Oncology Letters CrossRef
2. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
   S. L. George et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
3. Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer
   Mingfeng Yu et al, 2022, Journal of Medicinal Chemistry CrossRef
4. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells
   Junjira Suebsoonthron et al, 2017, Anti-Cancer Drugs CrossRef
5. Effects of Pyridostigmine bromide on SH-SY5Y cells: An in vitro neuroblastoma neurotoxicity model
   VerÔnica Farina Azzolin et al, 2017, Mutation Research/Genetic Toxicology and Environmental Mutagenesis CrossRef
6. Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities
   Esteban Zamudio-Martinez et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
7. Vitamin A regulates dermal papilla cell proliferation and apoptosis under heat stress via IGF1 and Wnt10b signaling
   Zhengkai Yue et al, 2023, Ecotoxicology and Environmental Safety CrossRef
8. Neural crest cells development and neuroblastoma progression: Role of Wnt signaling
   Mir Hilal Ahmad et al, 2023, Journal of Cellular Physiology CrossRef
9. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells
   Ozlem Kulak et al, 2015, Molecular and Cellular Biology CrossRef
10. Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells
    Sreenidhi Mohanvelu et al, 2024, Reference Module in Biomedical Sciences CrossRef
11. WNT Signaling in Neuroblastoma
    Juergen Becker et al, 2019, Cancers CrossRef